4.5 Review

Lamivudine for the treatment of HIV

Journal

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY
Volume 6, Issue 1, Pages 105-114

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1517/17425250903490418

Keywords

antiretroviral therapy; HIV; lamivudine; nucleoside reverse transcriptase inhibitor

Ask authors/readers for more resources

Lamivudine is a nucleoside reverse transcriptase inhibitor that is widely used for the treatment of HIV-1 infection in combination with other antiretrovirals. It is a highly effective agent that can be dosed once or twice daily due to its long intracellular half-life. it also has one of the best tolerability and long-term safety profiles among all antiretroviral agents and continues to be preferred as part of initial or subsequent combination therapy in HIV-infected patients.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available